|
Status |
Public on Dec 05, 2023 |
Title |
JIMT-1_CTL_3 |
Sample type |
RNA |
|
|
Source name |
Human HER2+ Breast Cancer Cells (JIMT-1)
|
Organism |
Homo sapiens |
Characteristics |
cell line: JIMT-1 cell type: HER2+ Breast Cancer
|
Treatment protocol |
HSL samples were treated with 1ug/ul of HSL119
|
Growth protocol |
Cells grown in DMEM (Corning 10-017-CV) supplemented with 10% fetal bovine serum, 200 nM glutamine (Thermo Scientific), and penicillin/streptomycin (Thermo Scientific). HUNK knockdown cells were grown in media with 1ug/ul puromycin
|
Extracted molecule |
total RNA |
Extraction protocol |
Used GeneJET RNA purifcation kit (K0732) to isolate RNA from cells.
|
Label |
n/a
|
Label protocol |
n/a
|
|
|
Hybridization protocol |
n/a
|
Scan protocol |
n/a
|
Data processing |
NanoString nSolver 4.0 software was used for analysis of gene expression values Nanostring nSolver 4.0 software computed normalized log2 count and normalized linear count
|
|
|
Submission date |
May 26, 2023 |
Last update date |
Dec 05, 2023 |
Contact name |
Elizabeth Yeh |
E-mail(s) |
[email protected]
|
Organization name |
Indiana University School of Medicine
|
Department |
Pharmacology and Toxicology
|
Street address |
635 Barnhill Drive, Medical Science Building A418
|
City |
Indianapolis |
State/province |
Indiana |
ZIP/Postal code |
46202 |
Country |
USA |
|
|
Platform ID |
GPL33436 |
Series (1) |
GSE233608 |
HSL119 results in gene expression changes equivalent to HUNK shRNA |
|